Drug
Arformoterol tartrate clinical trials
Also written Brovana.
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2002 (2)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2014 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 3
Sumitomo Pharma America, Inc. (6) · Dartmouth-Hitchcock Medical Center (1) · University of Massachusetts, Worcester (1) · Wake Forest University Health Sciences (1)
Often tested with
Tested in the same studies.
Budesonide (1) · Ipratropium (1) · Fluticasone-Salmeterol Drug Combination (1) · Tiotropium (1)
Related medicines
As reviewed, each with the page that says it.
- An enantiomer of Formoterol source
Studies
Open first, then newest update. How each study uses arformoterol tartrate is read from its arms, and is right about nine times in ten.
Testing it · 9
- Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)TerminatedPhase 4Wake Forest University Health SciencesNCT03219866Written as Brovana
- A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) SubjectsTerminatedPhase 4Sumitomo Pharma America, Inc.NCT02275481Written as Arformoterol tartrate inhalation solution
- Effect of Bronchodilation on Cycle vs Treadmill Exercise Endurance Time in COPDCompletedPhase 4Dartmouth-Hitchcock Medical CenterNCT00754546Written as Arformoterol tartrate
- A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3Sumitomo Pharma America, Inc.NCT00685841Written as Arformoterol tartrate inhalation solution
- Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRICompletedNot applicableUniversity of Massachusetts, WorcesterNCT00846287Written as Aformoterol
- Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedPhase 3Sumitomo Pharma America, Inc.NCT00250679Written as Arformoterol tartrate inhalation solution
- Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPDCompletedPhase 3Sumitomo Pharma America, Inc.NCT00064402Written as arformoterol tartrate inhalation solution
- Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPDCompletedPhase 4Sumitomo Pharma America, Inc.NCT00571428Written as Arformoterol Tartrate Inhalation Solution
- A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2Sumitomo Pharma America, Inc.NCT00691405Written as Arformoterol tartrate inhalation solution
As the comparator · 1 — what is tested is compared with arformoterol tartrate
Codes
What other systems call arformoterol tartrate · ClinicalTrials.gg INT015101
- UNII (FDA) 5P8VJ2I235ARFORMOTEROL TARTRATEConfirmed FDA, Wikidata
- RxNorm 668284Confirmed FDA, Wikidata
- Wikidata Q27262686arformoterol tartrateConfirmed FDA, Wikidata
- NCI Thesaurus C65240Arformoterol TartrateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 5P8VJ2I235 | ARFORMOTEROL TARTRATE | Confirmed FDA, Wikidata |
| RxNorm | 668284 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27262686 | arformoterol tartrate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C65240 | Arformoterol Tartrate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.